Albemarle (NYSE:ALB) Stock Price Target Lowered at Barclays

Posted by Francis Steltz on Nov 7th, 2026

Albemarle (NYSE:ALB – Free Report) had its target price reduced by Barclays from $109.00 to $95.00 in a report issued on Friday morning,Benzinga reports. Barclays currently has an equal weight rating on the specialty chemicals company’s stock.

Other equities analysts also recently issued research reports about the company. JPMorgan Chase & Co. reduced their price target on Albemarle from $160.00 to $140.00 and set a “neutral” rating for the company in a research report on Tuesday, August 25th. Citigroup decreased their price target on shares of Albemarle from $175.00 to $125.00 and set a “buy” rating for the company in a research note on Thursday, October 22nd. Scotiabank lowered their price objective on shares of Albemarle from $200.00 to $190.00 and set a “sector outperform” rating on the stock in a report on Monday, August 10th. Zacks Research lowered shares of Albemarle from a “hold” rating to a “strong sell” rating in a research report on Friday, October 9th. Finally, Truist Financial reduced their target price on shares of Albemarle from $225.00 to $185.00 and set a “buy” rating for the company in a report on Tuesday, October 20th. Fifteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and three have given a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average price target of $177.64.

Check Out Our Latest Stock Report on Albemarle

Albemarle Stock Up 0.7%

Shares of Albemarle stock traded up $0.66 during trading on Friday, reaching $99.03. The stock had a trading volume of 2,444,312 shares, compared to its average volume of 2,458,542. The company has a current ratio of 2.09, a quick ratio of 1.35 and a debt-to-equity ratio of 0.22. The company has a market capitalization of $11.69 billion, a price-to-earnings ratio of 23.92, a P/E/G ratio of 0.54 and a beta of 1.34. The stock has a fifty day moving average price of $107.59 and a two-hundred day moving average price of $147.87. Albemarle has a 52 week low of $89.77 and a 52 week high of $221.00.

Albemarle (NYSE:ALB – Get Free Report) last posted its quarterly earnings data on Wednesday, November 4th. The specialty chemicals company reported $2.58 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.53 by $0.05. The business had revenue of $1.55 billion during the quarter, compared to the consensus estimate of $1.52 billion. Albemarle had a return on equity of 10.96% and a net margin of 3.09%. Albemarle’s quarterly revenue was up 18.8% on a year-over-year basis. During the same period last year, the company earned ($0.19) earnings per share. Sell-side analysts predict that Albemarle will post 11.20 EPS for the current fiscal year.

Albemarle Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, January 4th. Shareholders of record on Friday, December 18th will be paid a $0.41 dividend. The ex-dividend date is Friday, December 18th. This represents a $1.64 dividend on an annualized basis and a yield of 1.7%. Albemarle’s dividend payout ratio (DPR) is currently 39.61%.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the company. Addison Advisors LLC acquired a new position in shares of Albemarle during the 2nd quarter worth about $28,000. Valley National Advisers Inc. raised its holdings in shares of Albemarle by 3,700.0% in the 3rd quarter. Valley National Advisers Inc. now owns 304 shares of the specialty chemicals company’s stock valued at $32,000 after purchasing an additional 296 shares during the period. NFSG Corp lifted its stake in Albemarle by 470.0% in the 3rd quarter. NFSG Corp now owns 342 shares of the specialty chemicals company’s stock valued at $36,000 after purchasing an additional 282 shares during the last quarter. Fiduciary Financial Advisors acquired a new stake in Albemarle in the 2nd quarter valued at about $41,000. Finally, Jones Financial Companies Lllp acquired a new stake in Albemarle in the 2nd quarter valued at about $42,000. Institutional investors own 92.87% of the company’s stock.

Trending Headlines about Albemarle

Here are the key news stories impacting Albemarle this week:

Positive Sentiment: Albemarle reported third-quarter adjusted earnings of $2.58 per share, ahead of estimates, on $1.55 billion in revenue—also above forecasts and up 18.8% year over year. Higher lithium pricing, strong demand, cost reductions and improved Specialties profits supported the results. Albemarle Q3 Earnings Call Highlights Cost Discipline and Lithium Demand
Positive Sentiment: Scotiabank maintained its “Sector Outperform” rating and $190 price target, estimating EPS of $11.64 for FY2026 and $14.15 for FY2027—above the cited current-year consensus estimate. Albemarle analyst coverage
Positive Sentiment: Truist reaffirmed its “buy” rating, though it lowered its price target to $170 from $185. Truist rating information
Neutral Sentiment: RBC cut its target to $119 from $129 but retained an “outperform” rating, reflecting a more cautious valuation alongside continued optimism about the shares. RBC rating information
Negative Sentiment: Barclays lowered its target to $95 from $109 and kept an “equal weight” rating, pointing to a less favorable near-term risk-reward view. Lithium prices remain volatile, a potential source of uncertainty for earnings. Barclays rating information

About Albemarle

(Get Free Report)

Albemarle Corporation (NYSE: ALB) is a global specialty chemicals company headquartered in Charlotte, North Carolina. The company develops, manufactures, and markets engineered chemicals used in energy storage, transportation, refining, pharmaceuticals, agriculture, consumer products, and other industrial applications.

Albemarle is one of the world’s major producers of lithium and supplies lithium compounds, including lithium carbonate and lithium hydroxide, for use in rechargeable batteries for electric vehicles, portable electronics, and grid energy-storage systems.